|
Aug 15
|
JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025
|
|
Aug 15
|
enVVeno Medical to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
|
|
Aug 6
|
Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency
|
|
Aug 4
|
enVVeno Medical Participates in a New Virtual Investor "What This Means" Segment to Discuss How President Trump's Recent CVI Diagnosis May Impact the Company
|
|
Aug 1
|
enVVeno Medical Reports Second Quarter 2025 Financial Results and Provides Corporate Update
|
|
Jul 22
|
enVVeno Medical Participates in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
|
|
Jul 22
|
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
|
|
Jul 18
|
JTC Team Announces Participating Line Up for the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
|
|
Jun 21
|
Positive Interim Venous Ulcer Healing Data Showing Significant Improvement from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented Today at the Society for Vascular Surgery 2024 Vascular Annual Meeting
|
|
Jan 6
|
enVVeno Medical Corporation's (NASDAQ:NVNO) Path To Profitability
|
|
Oct 26
|
enVVeno Medical Reports Third Quarter 2023 Financial Results and Provides Corporate Update
|